curiaglobal.com
Open in
urlscan Pro
141.193.213.20
Public Scan
Submitted URL: http://amriglobal.com/
Effective URL: https://curiaglobal.com/
Submission Tags: tranco_l324
Submission: On May 28 via api from DE — Scanned from DE
Effective URL: https://curiaglobal.com/
Submission Tags: tranco_l324
Submission: On May 28 via api from DE — Scanned from DE
Form analysis
1 forms found in the DOMGET https://curiaglobal.com
<form class="main-nav__global-search-form" action="https://curiaglobal.com" method="get" role="search" __bizdiag="115" __biza="WJ__"><button class="main-nav__global-search-submit" type="submit">
<svg class="icon__magnifying-glass" width="28px" height="28px" viewBox="0 0 28 28" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<title>Icon - Magnifying Glass</title>
<g id="icon__magnifying-glass--enclosing-group" stroke="none" stroke-width="1" fill="none" fill-rule="evenodd">
<g id="icon__magnifying-glass--search-icon-group" transform="translate(2.000000, 2.000000)" fill="#000000">
<path
d="M10.2644706,0 C4.59037174,0 0,4.59037174 0,10.2644706 C0,15.9385695 4.59037174,20.5289412 10.2644706,20.5289412 C12.4637914,20.5289412 14.5040451,19.8276123 16.1935016,18.6164191 L21.006939,23.4295909 C21.3256041,23.7485216 21.7720009,23.9394552 22.2183977,23.9394552 C22.6645289,23.9394552 23.1109257,23.7803881 23.4295909,23.4295909 L23.4614574,23.3977244 C24.1309198,22.728262 24.2265194,21.6126683 23.4614574,20.9750724 L18.6480201,16.1935016 C19.8276123,14.5040451 20.5605422,12.4640569 20.5605422,10.2644706 C20.5286756,4.59037174 15.9385693,0 10.2644705,0 M10.2644706,3.41077951 C14.0257818,3.41077951 17.1181617,6.47102734 17.1181617,10.2644706 C17.1181617,11.698995 16.6717649,13.0376542 15.8429699,14.2172465 L15.1735075,15.1735075 L14.2172465,15.8427044 C13.0376542,16.6714993 11.6987294,17.1178961 10.2644706,17.1178961 C6.50289385,17.1178961 3.41077951,14.0579139 3.41077951,10.2644706 C3.41077951,6.47102734 6.50289385,3.41077951 10.2644706,3.41077951">
</path>
</g>
</g>
</svg>
</button><input class="main-nav__global-search-input" type="text" name="s"></form>
Text Content
* Quick Quote * Curia Express * Government Contracting * News * Careers Icon - Magnifying Glass Curia - Logo - Full * About * Biologics * Research and Development * Manufacturing * Lab Testing * Insights Contact About Us icons/utility/right caret Partnering with Us icons/utility/right caret Our People icons/utility/right caret Our Facilities icons/utility/right caret Biologics Overview icons/utility/right caret Discovery icons/utility/right caret Beacon Molecular Biology Viral Vectors & Cell Engineering Antibody Discovery & Engineering Recombinant Antibody Production Recombinant Protein Production Development icons/utility/right caret Stable CHO Cell Line Upstream Process Development Downstream Process Development Formulation Development Analytical Development Antibody Developability Analysis FAQ Manufacturing icons/utility/right caret Mammalian GMP Overview Quality Systems Process Development Therapeutic GMP Manufacturing Diagnostic GMP Manufacturing Biorepository Service Analytical Development Assays & Bioanalytics icons/utility/right caret Bioanalytical Assays Biological and Functional Assays Resources icons/utility/right caret Sample Submission Forms Client Secure Portal Research & Development Overview icons/utility/right caret Discovery icons/utility/right caret Biology Lead Optimization Libraries Synthetic & Medicinal Chemistry Curia Express Development icons/utility/right caret Chemical Process R&D Clinical Manufacturing Fermentation Formulation Development High Potency Kilo Lab & Small-Scale GMP API Manufacturing Lipid Nanoparticle Method Development / Material Science Rare / Orphan Separation Science Consultative Services icons/utility/right caret Intellectual Property Litigation Support Intellectual Property Services Regulatory Support Quality Assurance Sterile University Manufacturing Overview icons/utility/right caret Custom API Manufacturing Fermentation Finished Dosage Form High Potency Lipid Nanoparticle Rare / Orphan Stability & Release Testing Sterile Fill Finish APIs & Intermediates Catalog Fine Chemicals Catalog Consultative Services icons/utility/right caret Intellectual Property Litigation Support Intellectual Property Services Regulatory Support Quality Assurance Sterile University Lab Testing Services Overview icons/utility/right caret Analytical Testing Services Batch Release & Stability Lot Testing Method Development & Validation Package & Device Testing Preformulation & Material Science Solid State Chemistry Curia - Logo - Full Icon - Magnifying Glass * About us icons/utility/right caret * Biologics icons/utility/right caret * Research & Development icons/utility/right caret * Manufacturing icons/utility/right caret * Lab Testing icons/utility/right caret * Insights * Contact us * Quick Quote * Curia Express * Government Contracting * News * Careers * Suppliers * About Us * Partnering with Us * Our People * Our Facilities * Biologics Overview * Discovery icons/utility/right caret * Development icons/utility/right caret * Manufacturing icons/utility/right caret * Assays & Bioanalytics icons/utility/right caret * Resources icons/utility/right caret * Research & Development Overview * Discovery icons/utility/right caret * Development icons/utility/right caret * Consultative Services icons/utility/right caret * Manufacturing Overview * Custom API Manufacturing * Fermentation * Finished Dosage Form * High Potency * Lipid Nanoparticle * Rare / Orphan * Stability & Release Testing * Sterile Fill Finish * APIs & Intermediates Catalog * Fine Chemicals Catalog * Consultative Services icons/utility/right caret * Lab Testing Overview * Analytical Testing Services * Batch Release & Stability Lot Testing * Method Development & Validation * Package & Device Testing * Preformulation & Material Science * Solid State Chemistry * Discovery Overview * Biology * Lead Optimization * Libraries * Synthetic & Medicinal Chemistry * Curia Express * Development Overview * Chemical Process R&D * Clinical Manufacturing * Fermentation * Formulation Development * High Potency * Kilo Lab & Small-Scale GMP API Manufacturing * Lipid Nanoparticle * Method Development / Material Science * Rare / Orphan * Separation Science * Consultative Services Overview * Intellectual Property Litigation Support * Intellectual Property Services * Regulatory Support * Quality Assurance * Sterile University * Beacon * Molecular Biology * Viral Vectors & Cell Engineering * Antibody Discovery & Engineering * Recombinant Antibody Production * Recombinant Protein Production * Stable CHO Cell Line * Upstream Process Development * Downstream Process Development * Formulation Development * Analytical Development * Antibody Developability Analysis * FAQ * Mammalian GMP Overview * Quality Systems * Process Development * Therapeutic GMP Manufacturing * Diagnostic GMP Manufacturing * Biorepository Service * Analytical Development * Bioanalytical Assays * Biological and Functional Assays * Sample Submission Forms * Client Secure Portal * Lab Testing Services Overview * Analytical Testing Services * Batch Release & Stability Lot Testing * Method Development & Validation * Package & Device Testing * Solid State Chemistry * Consultative Services Overview * Intellectual Property Litigation Support * Intellectual Property Services * Regulatory Support * Quality Assurance * Sterile University icons/utility/left caret About Us icons/utility/left caret Biologics icons/utility/left caret Research & Development icons/utility/left caret Manufacturing icons/utility/left caret Lab Testing icons/utility/left caret Discovery icons/utility/left caret Development icons/utility/left caret Manufacturing icons/utility/left caret Assays & Bioanalytics icons/utility/left caret Resources icons/utility/left caret Discovery icons/utility/left caret Development icons/utility/left caret Lab Testing Services icons/utility/left caret Consultative Services icons/utility/left caret Consultative Services Icon - Magnifying Glass Close Button EVENT UNLOCKING HIGH-THROUGHPUT BIOLOGY IN DRUG DISCOVERY Join Curia and Carterra for our 2024 Symposium Series. Attend to discuss the latest technologies in antibody discovery, AI/ML, and small molecule applications. There is no cost to attend, but seating is limited. Reserve your seat today! May 31, 2024 Register Now CURIA INSIGHTS IN VITRO CHARACTERIZATION OF A DUAL ANTAGONISTIC ANTI-LILRB2/LILRB4 MONOCLONAL ANTIBODY Available now! Our recent AACR Annual Meeting poster presentation co-authored with Tonix Pharmaceuticals titled “In Vitro Characterization of a Dual Antagonistic Anti-LILRB2/LILRB4 Monoclonal Antibody” where presenters discussed anti-LILRB2/LILRB4 monoclonal antibody. Download CURIA INSIGHTS THE SHIFT TOWARD WESTERN PHARMACEUTICAL MANUFACTURING: CONSIDERATIONS IN ATTAINING THE RIGHT GLOBAL MIX In this white paper we discuss effective strategies to secure and de-risk pharmaceutical supply chains and reveal how Curia assures the continual production of urgently needed drugs. Learn More EVENT BIO INTERNATIONAL CONVENTION Curia is a trusted partner to support you at any stage of your product development. We specialize in complex chemistry and deliver consistent quality that seamlessly scales to the next phase. Schedule a meeting or come by booth 4607. June 3 - 6, 2024 Schedule a Meeting CURIA SERVICES STERILE FILL FINISH MANUFACTURING From formulation / process development to clinical phase production and commercial sterile manufacturing, Curia offers the capacity, flexibility and scalability to bring your product to market. Learn More 1. 2. 3. 4. 5. The latest Curia and Carterra Partner on Biologics Symposium to Further Biotechnology Research in the Pacific Northwest F8E87338-1FC1-4EEF-B1C3-4A13B1DAB056 END-TO-END CAPABILITIES The journey to medical breakthrough may be linear, but it’s never simple. From discovery through manufacturing, launch through commercialization, we leverage deep scientific expertise and state-of-the-art technology to ensure every stage of this intricate process advances as quickly and accurately as possible. Group Group Continuum Capability spotlight EXPLORE OUR LATEST INNOVATIONS AND ADVANCED CAPABILITIES ANTIBODY DISCOVERY CAPABILITIES RARE / ORPHAN HIGH POTENCY SOME BONDS CAN’T BE BROKEN Science is objective. Measured. Rational. That doesn’t mean it’s heartless. From discovery and development through manufacturing and beyond, Curia balances the science of impact with the art of possibility, working together with our partners to not only deliver therapies, but change lives for the better. DISCOVER THE LATEST FROM OUR EXPERTS More insights icons/utility/caret 040E93C7-D189-4233-A102-58C0580BE529 publications patents Poster: In Vitro Characterization of a Dual Antagonistic Anti-LILRB2/LILRB4 Monoclonal Antibody icons/content-types/article article Trends and Challenges in the Pharmaceutical Industry icons/content-types/white paper white paper Continuous Flow – An Emerging Alternative READY TO MOVE FROM IDEA TO IMPACT? Get started * Careers * Suppliers * Contact us * About us * Biologics * Research & Development * Manufacturing * Lab Testing * Insights Curia and Carterra Partner on Biologics Symposium to Further Biotechnology Research in the Pacific Northwest May 9, 2024 Curia Appoints Steve Lavezoli as Vice President, Biologics February 23, 2024 More News icons/utility/right caret Curia - Logo - Molecules ©2024 Curia Global, Inc. All rights reserved. Do not sell my personal information | Privacy Policy|Terms of Use|Terms & Conditions Icon LinkedIn Icon Twitter Icon Facebook The trade/service marks used herein are the property of Curia or their respective owners. Use of the ® symbol indicates that the mark has been registered in at least the United States. Use of the TM or SM symbol indicates that the mark is in use in at least the United States. NOTICE: Please Be Aware of False Employment Opportunities Any job applicant who applies to Curia must submit their application through Curia’s career page at https://careers.curiaglobal.com. Applicants will only receive communication, including offer letters, from a curiaglobal.com email address. Please be aware that recent scams used email addresses that are similar to Curia addresses or use other public domain addresses such as gmail.com, yahoo.com and aol.com. Please confirm the sender’s email address prior to sharing your information. Thank you. CLOSE